書籍詳細

参考文献

P.159 掲載の参考文献

• 1. Yasue H, Horio Y, Nakamura N, Fujii H, Imoto N, Sonoda R, Kugiyama K, Obata K, Morikami Y, Kimura T.:Induction of coronary artery spasm by acetylcholine in patients with variant angina:possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation 1986;74:955-963.
  pubmed

• 2. Okumura K, Yasue H, Matsuyama K, Goto K, Miyagi H, Ogawa H, Matsuyama K.:Sensitivity and specificity of intracoronary injection of acetylcholine for the induction of coronary artery spasm. J Am Coll Cardiol 1988;12:883-888.
  pubmed

• 3. Okumura K, Yasue H, Horio Y, Takaoka K, Matsuyama K, Kugiyama K, Fujii H, Morikami Y.:Multivessel coronary spasm in patients with variant angina:a study with intracoronary injection of acetylcholine. Circulation 1988;77:535-542.
  pubmed

• 4. Prinzmetal M, Kennamer R, Merliss R, Wada T, Bor N.:Angina pectoris. I. A variant form of angina pectoris;preliminary report. Am J Med 1959;27:375-388.

• 5. Ong P, Athanasiadis A, Borgulya G, Voksi I, Bastiaenen R, Kubik S, Hill S, Schaufele T, Mahrholdt H, Kaski JC, Sechtem U.:Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries. Circulation 2014;129:1723-1730.
  pubmed

• 6. 末田章三, 河野浩明, 福田浩, 井上勝次, 鈴木純, 渡邊浩毅:冠攣縮性狭心症に典型的安静時胸痛例が多いか? 愛媛医学 2002;21:79-83.

• 7. 末田章三, 大下晃, 井添洋輔, 河野浩明, 福田浩:冠攣縮の認識不足がもたらす将来へのリスク. J Cardiolo 2007;49:83-90

• 8. Sueda S, Kohno H, Yoshino H.:The real world in the clinic before and after the establishment of guideleines for coronary artery spasm:a quentionnaire for members of the Japanese Cine-angio Association. Haeat and Vessels 2016;doi:10.1007/s00380-016-0916-9

• 9. Sueda S, Miyoshi T, Sasaki Y, Sakaue T, Habara H, Kohno H.:Approximately half of patients with coronary spastic angina had pathologic exercise tests. J Cardiol 2016;68(1)13-19.
  pubmed

• 10. Sueda S, Mineoi K, Kondo T, Yano K, Ochi T, Ochi N, Fukuda H, Kukita H, Kawada H, Katsuda S, Uraoka T.:Absence of induced spasm by intracoronary injection of 50gacetylcholine in the right coronary artery:usefulness of 80gg of acetylcholine as a spasm provocation test. J Cardiol 1998;32:155-161(in Japanese).

• 11. Sueda S, Kohno H, Miyoshi T, Sakaue T, Sasaki Y, Habara H.:Maximal acetylcholine dose of 200 Sg into the left coronary artery as a spasm provocation test:comparison with 100 gg of acetylcholine. Heart Vessels 2015;30:771-778.

• 12. JCS Joint Working Group.:Guidelines for diagnosis and treatment of patients with vasospastic angina(coronary spastic angina)(JCS 2015):Digest version. Circ J 2014;78:2779-2801.

• 13. Ong P, Athabasiadis A, Borgulya G, Mahrholdt H, Kaski JC, Secctem Udo.:High prevalence of a pathological reponse to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries:The ACOVA study. J Am Coll Cardiol 2012;59:655-662.

• 14. Sueda S, Kohno H, Fukuda H, Ochi N, Kawada H, Hayashi Y, Uraoka T.:Frequency of provoked coronary spasms in patients undergoing coronary arteriography using a spasm provocation test via intracoronary administration of ergonovine. Angiology 2004;55:403-411.
  pubmed

• 15. Sueda S, Kohno H, Ochi T, Uraoka T.:Overview of the acetylcholine spasm provocation test. Clinical Cardiol 2015;38:430-438

• 16. Sueda S, Miyoshi T, Sasaki Y, Sakaue T, Habara H, Kohno H.:Sequential spasm provocation tests might overcome a limitation of the standard spasm provocation tests. Coron Artery Dis 2015;D-15-00095R3 2015;26:490-494.

• 17. Sueda S, Miyoshi T, Sasaki Y, Sakaue T, Habara H, Kohno H.:Gender differences in sensitivity of acetylcholine and ergonvoine to coronary spasm provocation test. Heart Vessels 2016;31:322-329.
  pubmed

• 18. Sueda S, Ochi T, Yano K, Mineoi K, Kondou T, Ochi N, Hayashi Y, Kukita H, Matsuda S, Kawada H, Tsuruoka T, Uraoka T.:A newly-combined spasm provocation test In patients with rest angina:An intracoronary injection of acetylcholine following an intracoronary administration of ergonovine. Jpn Circ J 2000;64:559-565.
  pubmed

• 19. Sueda S, Kohno H, Ochi T, Uraoka T, Tsunemitsu K.:Overview of the pharmacological spasm provocation test:comparisons between acetylcholine and ergonovine. J Cardiol 2017;69:57-65.
  pubmed

• 20. Sueda S, Kohno H, Fukuda H, Watanabe K, Ochi N, Kawada H, Uraoka T.:Limitations of medical therapy in patients with pure coronary spastic angina. Chest 2003;123:380-386.
  pubmed

• 21. Sueda S, Sasaki Y, Habara H, Kohno H.:Silent coronary spastic angina:A report of a case. 2015 doi:10.1016/j.jccase. 2015.02.003

• 22. Yasue H, Mizuno Y, Harada E, Itoh T, Nakagawa H, Nakayama M, Ogawa H, Tayama S, Honda T, Hokimoto S, Ohshima S, Hokamura Y, Kugiyama K, Horie M, Yoshimura M, Harada M, Uemura S, Saito Y:SCAST(Statin and Coronary Artery Spasm Trial)Investigators. Effects of a 3-hydroxy-3-methylgutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers. J Am Coll Cardiol 2008;51:1742-1748.

• 23. 末田章三:たかが冠攣縮, されど冠攣縮. メディカ出版, 2016.

• 24. Beltrame F, Crea F, Kaski JC, Ogawa H, Ong P, Sechtem U, Shimokawa H, Merz CN on behalf of On Behalf of the Coronary Vasomotion Disorders International Study Group(COVADIS):The who, what, why, when, how and where of vasospastic anina. Circ J 2016;80:289-298.

• 25. Sueda S, Kohno H.:Impact of pharmacological spasm provocation tests in patients with a history of syncope. Heart Vesselo 2018;33:126-133.
  pubmed

• 26. Sueda S, Kohno H.:Optimal medications and appropriate implatable cardioverterdefibrillator shocks in aborted sudden cardiac death due to coronary spasm. Intern Med 2018 San 11. doi:10.2169/internal medicine, 8796-17.

• 27. Sueda S, Kohno H, Miyoshi T, Sasaki Y, Sakaue T, Habara H.:Spasm provocation tests performed under medical therapy:A new approach for treating patients with refractory coronary spastic angina on emergency admission. Intern Med 2014;53:1739-1747.
  pubmed